feed,title,long_url,short_url
Benzinga,FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections,https://benzinga.com/general/biotech/23/04/31852366/fdas-adcomm-panel-favors-innovivas-drug-for-multidrug-resistant-bacterial-infections,https://da.gd/1cG3uT
